Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d7bffbf26cb6d2384eeaa8c1e822585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b14e936224599e9ceef6151c235adf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d7e0d2e0817f1dddd62ab9fbf891f8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce137c75ca056835383846702d16e8a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb9e53a1e44bae9630fab7168b480929 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052 |
filingDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a57b717edcdf065d6a6f3ce40ff1164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9fc5bd49bcfe41312b48c402ab7ed5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63ee5579b07cbd01627e27c845d2620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18be76cfb930568280ea428b26bcec6a |
publicationDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005016255-A2 |
titleOfInvention |
Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds |
abstract |
This invention relates to substituted tetrahydroquinoline phenylacetic acids and benzoic acids that bind to and/or modulate hepatocyte factor 4α receptors and to methods for making and using such compounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013149996-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013149997-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054138-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008545803-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893082-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006002726-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7915416-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006312800-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7250423-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2647628-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2647638-A1 |
priorityDate |
2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |